24th Oct 2022 14:35
Angle PLC - Surrey, England-based medical diagnostics company - Says proof of concept study shows that both circulating tumour cells and cell-free circulating tumour DNA can be analysed from a single blood sample. "The results show that removal of plasma from blood samples for circulating tumour DNA analysis does not impact on the number or quality of circulating tumour cells which can be successfully isolated from the same sample using the Parsortix system," it explains. Read More
